CFA, Partner & Managing Director
Ally Bridge Group (ABG)
Charles Chon, CFA is Partner and Managing Director at Ally Bridge Group (ABG), a global healthcare fund based in Hong Kong. Mr. Chon leads ABG’s Medical Technologies effort and has been instrumental in numerous ABG investments. Currently, he serves as a director on the boards of Minneapolis-based companies, NxThera and Conventus Orthopedics. Prior to joining ABG as a founding member in 2013, Mr. Chon was a healthcare public equities research analyst for over 13 years on both the buy-side and sell-side. The majority of that time was at Goldman Sachs as Vice President, senior equity research analyst on the US medical devices team. From there, Mr. Chon became Sector Head, US medical devices research at Stifel Nicolaus. Mr. Chon holds the CFA designation, and received his MBA in healthcare management from Boston University and BA in Chemistry from Amherst College.